Benjamin F. Edwards & Company, Inc. Novartis Ag Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 6,559 shares of NVS stock, worth $733,755. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,559
Previous 6,327
3.67%
Holding current value
$733,755
Previous $612,000
14.05%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.32 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.16 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$963 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$789 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$757 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...